RIGL

Rigel Pharmaceuticals Inc. (New)

37.48

USD

RIGL Earnings Reports

Positive Surprise Ratio

RIGL beat 30 of 40 last estimates.

75%

Next Report

Date of Next Report

Mar 02, 2026

Estimate for Q4 25 (Revenue/ EPS)

$69.55M

$1.20

Implied change from Q3 25 (Revenue/ EPS)

+0.12%

-17.81%

Implied change from Q4 24 (Revenue/ EPS)

+20.75%

+50.00%

Rigel Pharmaceuticals Inc. (New) earnings per share and revenue

On Nov 04, 2025, RIGL reported earnings of 1.46 USD per share (EPS) for Q3 25, beating the estimate of 0.87 USD, resulting in a 67.47% surprise. Revenue reached 69.46 million, compared to an expected 63.12 million, with a 10.05% difference. The market reacted with a +33.37% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 7 analysts forecast an EPS of 1.20 USD, with revenue projected to reach 69.55 million USD, implying an decrease of -17.81% EPS, and increase of 0.12% in Revenue from the last quarter.

FAQ

What were Rigel Pharmaceuticals Inc. (New)'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Rigel Pharmaceuticals Inc. (New) reported EPS of $1.46, beating estimates by 67.47%, and revenue of $69.46M, 10.05% above expectations.

How did the market react to Rigel Pharmaceuticals Inc. (New)'s Q3 2025 earnings?

The stock price moved up 33.37%, changed from $28.38 before the earnings release to $37.85 the day after.

When is Rigel Pharmaceuticals Inc. (New) expected to report next?

The next earning report is scheduled for Mar 02, 2026.

What are the forecasts for Rigel Pharmaceuticals Inc. (New)'s next earnings report?

Based on 7 analysts, Rigel Pharmaceuticals Inc. (New) is expected to report EPS of $1.20 and revenue of $69.55M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.